Open an Account
search icon
4
NOTIFICATIONS
Best Algo trading app in India

Back Stocks profile

Stock analysis tool for investors

GlaxoSmithKline Pharmaceuticals Ltd.

NSE: GLAXO | BSE:500660

₹2603.70 -15.05 (-0.57%) 1D

Pharmaceuticals & Biotechnology

Buy Sell
View detailed Technical chart

Open an Account with Bigul in 5 minutes

Performance

Today’s low

2598.00

Today’s High

2674.00

52W low

1377.20

52W High

2760.00

Open Price

2620.10

Prev. Close

2464.9000

Volume

93954.00

Value

244628029.80

Fundamentals

Market Cap Cr

44108.20

Price to Earnings

74.80

Price to Book Value

24.80

Dividend Yield

1.20

PE to Growth

-22.00

Op Revenue TTM Cr

3453.71

Net Profit TTM Cr

589.96

Cash From Operating Activity Cr

582.02

Return on Equity %

33.42

EMA & SMA

Bullish Moving Averages

11

Bearish Moving Averages

5

5Day EMA

2617.1

10Day EMA

2613.5

12Day EMA

2608.6

20Day EMA

2574.5

26Day EMA

2541.3

50Day EMA

2419.4

100Day EMA

2256.3

200Day EMA

2043.4

5Day SMA

2631.2

10Day SMA

2610.5

20Day SMA

2599.7

30Day SMA

2556.8

50Day SMA

2368

100Day SMA

2216.5

150Day SMA

2136.6

200Day SMA

1982.7

DELIVERY AND VOLUME

DAILY AVG. DELIVERY VOLUME %

03 Jul, 2024

48

Week

57.4

Month

57

LEGEND

Positive Indicator

Neutral Indicator

Negative Indicator

RESISTANCE AND SUPPORT

2625.25

PIVOT

First Resistance

2652.45

Second Resistance

2701.20

Third Resistance

2728.40

First Support

2576.50

Second Support

2549.30

Third Support

2500.55

Relative Strength Index

55.66

Money Flow Index

74.53

MACD

67.23

MACD Signal

84.14

Average True Range

98.74

Average Directional Index

24.45

Rate of Change (21)

4.37

Rate of Change (125)

33.42

Commodity Channel Index

26

Williams %R

-60

BETA

1 Month

0.65

3 Month

0.62

1 Year

0.58

3 Year

0.17

PRICE CHANGE ANALYSIS

↓ -1.43%

1 Week

Low

High

2592

2700

↓ -0.6%

1 Month

Low

High

2235

2760

↑ 32.12%

3 Months

Low

High

1842.05

2760

↑ 27.07%

6 Months

Low

High

1842.05

2760

↑ 82.7%

1 Year

Low

High

1377.25

2760

Indicator Mar 2024 Dec 2023 Sep 2023 Jun 2023 Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022 Dec 2021 Sep 2021 Graph
Total Qtr Revenue cr 940.74 833.32 981.85 774.82 810.13 822.71 927.77 757.25 810.86 818.48 1006.58
Operating Expenses Qtr 655.56 587.47 666.80 596.77 615.40 571.31 648.69 581.53 618.50 611.32 717.14
Operating Profit Qtr 255.31 217.51 286.58 141.25 166.76 227.80 256.92 147.93 173.42 196.66 274.39
EBIDT Qtr Cr 287.58 82.54 315.05 195.35 205.13 240.03 279.08 178.77 1495.57 201.31 289.44
Depreciation Qtr 18.10 17.11 18.11 16.36 17.18 16.41 16.36 15.82 15.35 17.87 17.60
Net Profit Qtr 193.08 45.49 215.54 130.58 131.48 164.03 193.56 118.68 1217.84 149.63 202.65
Basic EPS Qtr 11.29 9.88 12.72 6.94 7.28 9.68 11.42 7.01 71.89 8.83 11.96
Indicator Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Graph
Total Revenue Annual 3530.73 3317.86 3293.72 3030.66 3302.24
Operating Expenses Annual Cr 2506.60 2416.92 2461.68 2322.70 2566.23
Operating Profit Annual 900.65 799.43 755.83 597.77 658.45
Operating Profit Margin Annual % 25.51 24.09 22.95 19.72 19.94
Total Expenses Annual Cr 2578.08 2484.50 2531.86 2404.84 2655.24
EBIDT Annual Cr 1024.13 900.94 832.04 707.96 736.01
EBIDT Annual margin % 29.01 27.15 25.26 23.36 22.29
Depreciation 69.68 65.77 68.19 78.60 82.68
PAT Before ExtraOrdinary Items Annual Cr 584.69 604.71 376.58 286.69 110.05
Net Profit Annual 584.69 607.75 1690.53 357.57 110.05
Basic EPS Annual 40.83 35.90 99.05 31.32 6.50
Indicator Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Graph
Total ShareHolders Funds Annual 1784.09 1753.00 2677.62 1497.12 1840.04
Minority Interest Liability Annual Cr - - - - -
Total Non Current Liabilities Annual Cr 252.76 257.67 270.63 280.54 289.41
Total Current Liabilities Annual Cr 1510.94 1317.03 1674.35 1319.42 1002.07
Total Capital Plus Liabilities Annual Cr 3547.80 3327.70 4622.60 3097.08 3131.52
Fixed Assets Annual 335.18 350.25 361.13 400.10 878.18
Total Non Current Assets Annual 781.96 860.98 951.89 925.75 1374.74
Total Current Assets Annual 2765.84 2466.72 3670.71 2171.33 1756.78
Total Assets Annual 3547.80 3327.70 4622.60 3097.08 3131.52
Contingent Liabilities plus Commitments Annual Cr 383.96 358.51 365.29 493.24 483.04
Indicator Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Graph
Cash from Operating Activity Annual 578.94 487.94 819.79 594.87 490.97
Cash from Investing Activity Annual 14.97 805.19 -419.66 407.57 -63.10
Cash from Financing Annual Activity -561.50 -1544.18 -524.24 -695.56 -427.62
Net Cash Flow Annual 32.41 -251.05 -124.11 306.87 0.25
Indicator Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Graph
Book Value Per Share Annual 105.31 103.48 158.06 88.37 108.62
ROE Annual % 32.77 34.66 63.13 23.88 5.98
ROCE Annual % 46.85 41.53 25.90 35.40 30.68
Total Debt to Total Equity Annual 0.00 0.00 0.00 0.00 0.00
EBDIT Annual Margin % 30.05 28.01 25.85 24.24 22.82
Indicator Mar 2024 Dec 2023 Sep 2023 Jun 2023 Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022 Dec 2021 Sep 2021 Graph
Total Qtr Revenue cr 959.63 833.37 985.20 798.10 815.11 825.72 938.84 772.71 828.39 826.24 1024.84
Operating Expenses Qtr 672.54 587.20 667.50 617.78 617.71 573.60 659.94 596.18 634.41 618.11 733.35
Operating Profit Qtr 257.26 218.06 289.49 143.88 169.74 228.70 256.93 148.92 175.22 197.81 276.52
EBIDT Qtr Cr 289.49 82.86 317.70 197.62 207.80 240.75 278.90 179.58 1497.19 202.28 291.49
Depreciation Qtr 18.10 17.11 18.11 16.36 17.18 16.41 16.36 15.82 15.35 17.87 17.60
Net Profit Qtr 194.48 45.72 217.51 132.25 133.43 164.56 193.42 119.28 1219.05 150.35 204.24
Basic EPS Qtr 11.37 9.89 12.84 7.04 7.41 9.71 11.42 7.04 71.96 8.88 12.06
Indicator Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Graph
Total Revenue Annual 3576.30 3352.38 3353.80 3036.18 3303.39
Operating Expenses Annual Cr 2545.02 2447.44 2516.15 2327.46 2567.13
Operating Profit Annual 908.69 804.29 761.88 598.14 657.25
Operating Profit Margin Annual % 25.41 23.99 22.72 19.70 19.90
Total Expenses Annual Cr 2616.50 2515.02 2586.33 2409.60 2656.15
EBIDT Annual Cr 1031.28 904.95 837.65 708.72 736.26
EBIDT Annual margin % 28.84 26.99 24.98 23.34 22.29
Depreciation 69.68 65.77 68.19 78.60 82.68
PAT Before ExtraOrdinary Items Annual Cr 589.96 607.64 380.77 287.27 93.20
Net Profit Annual 594.13 616.72 1694.72 358.15 93.20
Basic EPS Annual 41.14 36.05 100.04 21.14 5.50
Indicator Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Graph
Total ShareHolders Funds Annual 1777.64 1741.27 2662.96 1478.26 1820.60
Minority Interest Liability Annual Cr 0.00 0.00 0.00 0.00 0.00
Total Non Current Liabilities Annual Cr 254.03 258.94 271.89 281.81 290.68
Total Current Liabilities Annual Cr 1524.95 1326.37 1698.43 1354.58 1021.95
Total Capital Plus Liabilities Annual Cr 3556.62 3326.58 4633.28 3114.65 3133.23
Fixed Assets Annual 335.20 350.27 361.15 400.12 878.21
Total Non Current Assets Annual 758.20 832.32 925.25 912.01 1358.35
Total Current Assets Annual 2798.42 2494.26 3708.03 2202.64 1774.88
Total Assets Annual 3556.62 3326.58 4633.28 3114.65 3133.23
Contingent Liabilities plus Commitments Annual Cr 387.14 361.80 368.97 498.50 488.30
Indicator Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Graph
Cash from Operating Activity Annual 582.02 484.23 810.75 577.93 490.50
Cash from Investing Activity Annual 8.71 807.85 -405.51 418.59 -56.84
Cash from Financing Annual Activity -561.50 -1543.32 -524.24 -696.14 -427.62
Net Cash Flow Annual 29.23 -251.25 -119.00 300.38 6.03
Indicator Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Graph
Book Value Per Share Annual 104.93 102.79 157.19 87.26 107.47
ROE Annual % 33.42 35.41 63.64 24.22 5.11
ROCE Annual % 47.33 41.95 26.21 35.80 30.95
Total Debt to Total Equity Annual 0.00 0.00 0.00 0.00 0.00
EBDIT Annual Margin % 29.86 27.82 25.55 24.22 22.83
Name Holding Percent Holding Id Pledged % Locked %
ADITYA BIRLA SUN LIFE TRUSTEE PRIVATE LIMITED A/C 1.01 73805913 - -
Name Holding Percent Holding Id Pledged % Locked %
GLAXO GROUP LIMITED 35.99 73805907 0 0
GLAXOSMITHKLINE PTE LIMITED 28.1 73805908 0 0
ESKAYLAB LIMITED 6.94 73805909 0 0
BURROUGHS WELLCOME INTERNATIONAL LIMITED 3.97 73805910 0 0
Name Holding Percent Holding Id
ADITYA BIRLA SUN LIFE TRUSTEE PRIVATE LIMITED A/C 1.01 73805913
LICI ASM NON PAR 1.94 73805915
Name Holding Percent Holding Id
Ex-Date Dividend Amount Dividend Type Record Date Instrument Type
May 31, 2024 32 FINAL May 31, 2024 Equity Share
Jun 30, 2023 32 FINAL Jun 30, 2023 Equity Share
Jul 07, 2022 60 SPECIAL Jul 08, 2022 Equity Share
Jul 07, 2022 30 FINAL Jul 08, 2022 Equity Share
Jul 19, 2021 30 FINAL Jul 20, 2021 Equity Share
Jul 17, 2020 20 SPECIAL Jul 20, 2020 Equity Share
Jul 17, 2020 20 FINAL Jul 20, 2020 Equity Share
Jul 11, 2019 20 FINAL - Equity Share
Jul 13, 2018 35 FINAL - Equity Share
Jul 14, 2017 30 FINAL - Equity Share
Jul 15, 2016 50 FINAL - Equity Share
Jul 23, 2015 62.5 FINAL - Equity Share
Apr 03, 2014 50 FINAL - Equity Share
Apr 04, 2013 50 FINAL - Equity Share
Mar 29, 2012 45 FINAL - Equity Share
Mar 14, 2011 40 FINAL - Equity Share
Mar 10, 2010 30 FINAL - Equity Share
Mar 18, 2009 40 FINAL - Equity Share
Apr 02, 2008 36 FINAL - Equity Share
Mar 14, 2007 31 FINAL - Equity Share
Mar 24, 2006 28 FINAL - Equity Share
Mar 16, 2005 24 FINAL - Equity Share
Feb 25, 2004 10 FINAL - Equity Share
Apr 10, 2003 7 FINAL - Equity Share
Mar 27, 2002 - FINAL - Equity Share
May 02, 2001 - FINAL - Equity Share
Ex-Date Split Ratio Record Date
Ex-Date Purpose Notes
May 17, 2024 Audited Results & Final Dividend -
Feb 12, 2024 Quarterly Results -
Nov 09, 2023 Quarterly Results -
Jul 26, 2023 Quarterly Results -
May 17, 2023 Audited Results & Final Dividend -
Feb 07, 2023 Quarterly Results -
Nov 11, 2022 Quarterly Results -
Jul 25, 2022 Quarterly Results -
May 16, 2022 Audited Results & Dividend -
Feb 07, 2022 Quarterly Results -
Oct 29, 2021 Quarterly Results -
Jul 26, 2021 Quarterly Results -
May 18, 2021 Audited Results & Dividend -
Feb 05, 2021 Quarterly Results -
Oct 28, 2020 Quarterly Results -
Jul 29, 2020 Quarterly Results -
May 18, 2020 Audited Results & Final Dividend -
Feb 03, 2020 Quarterly Results -
Oct 22, 2019 Quarterly Results -
Jul 22, 2019 Quarterly Results -
May 20, 2019 Audited Results & Dividend -
Feb 04, 2019 Quarterly Results -
Oct 22, 2018 Quarterly Results -
Jul 24, 2018 Quarterly Results & Bonus issue -
May 24, 2018 Audited Results & Dividend -
Feb 02, 2018 Quarterly Results -
Oct 25, 2017 Quarterly Results -
Jul 25, 2017 Quarterly Results -
May 19, 2017 Audited Results & Dividend -
Feb 11, 2017 Quarterly Results -
Oct 27, 2016 Quarterly Results -
Jul 28, 2016 Quarterly Results -
May 25, 2016 Audited Results & Dividend The Ninety First Annual General Meeting of the Company will be held on July 28, 2016 at the Birla Matushri Sabhagar, 19, Marine Lines, Mumbai 400020.
Feb 10, 2016 Quarterly Results -
Oct 31, 2015 Quarterly Results -
Jul 31, 2015 Quarterly Results -
May 18, 2015 Audited Results & Dividend -
Feb 12, 2015 Quarterly Results -
Nov 06, 2014 Quarterly Results -
Aug 12, 2014 Quarterly Results -
Apr 17, 2014 Quarterly Results -
Feb 18, 2014 Audited Results & Dividend -
Nov 11, 2013 Quarterly Results -
Aug 07, 2013 Quarterly Results -
May 07, 2013 Quarterly Results -
Feb 19, 2013 Audited Results & Dividend -
Nov 09, 2012 Quarterly Results -
Aug 13, 2012 Quarterly Results -
May 07, 2012 Quarterly Results -
Feb 16, 2012 Audited Results & Dividend -
Nov 04, 2011 Quarterly Results -
Aug 10, 2011 Quarterly Results -
May 06, 2011 Quarterly Results -
Feb 14, 2011 Audited Results & Dividend -
Oct 28, 2010 Quarterly Results -
Jul 26, 2010 Quarterly Results -
Apr 27, 2010 Quarterly Results -
Feb 15, 2010 Audited Results & Dividend -
Oct 30, 2009 Quarterly Results -
Jul 27, 2009 Quarterly Results -
Apr 28, 2009 Quarterly Results -
Feb 18, 2009 Audited Results & Dividend -
Oct 24, 2008 Quarterly Results -
Jul 28, 2008 Quarterly Results -
Apr 21, 2008 Quarterly Results -
Feb 22, 2008 Audited Results & Dividend -
Oct 25, 2007 Quarterly Results -
Jul 26, 2007 Quarterly Results & Half Yearly Results -
Apr 27, 2007 Quarterly Results -
Feb 16, 2007 Accounts & Dividend -
Oct 30, 2006 Quarterly Results -
Jul 26, 2006 Quarterly Results -
Apr 28, 2006 Quarterly Results -
Feb 13, 2006 Accounts & Dividend -
Oct 28, 2005 Quarterly Results -
Jul 26, 2005 Quarterly Results -
Apr 29, 2005 Quarterly Results -
Mar 15, 2005 Buy Back of Shares -
Feb 15, 2005 Dividend & Accounts -
Oct 29, 2004 Quarterly Results -
Jul 28, 2004 Quarterly Results -
Apr 23, 2004 Quarterly Results -
Mar 17, 2004 Amalgamation Consider the proposal of merger of Burroughs Wellcome (India) Ltd. with the company and also to approve the Scheme of Amalgamation and other related matters.
Feb 06, 2004 Dividend & Accounts -
Oct 28, 2003 Quarterly Results -
Jul 28, 2003 Half Yearly Results -
Apr 28, 2003 Quarterly Results -
Mar 12, 2003 Accounts & Dividend -
Oct 31, 2002 Quarterly Results -
Jul 26, 2002 Half Yearly Results -
Apr 26, 2002 Quarterly Results -
Mar 04, 2002 Accounts & Dividend -
Oct 25, 2001 Quarterly Results -
Jul 27, 2001 Quarterly Results -
Apr 27, 2001 Quarterly Results -
Feb 23, 2001 Amalgamation & Merger To consider the proposal of merger of the company with Smithkline Beecham Pharmaceuticals (India) Ltd. and also to approve the scheme of Amalgamation and other related matters.
Feb 07, 2001 Dividend & Accounts -
Oct 30, 2000 Quarterly Results -
Jul 26, 2000 Quarterly Results -
Feb 17, 2000 Accounts & Dividend -
Oct 25, 1999 Quarterly Results -
Jul 29, 1999 Quarterly Results -
May 04, 1999 Quarterly Results -
Oct 27, 1998 Quarterly Results -
Jul 27, 1998 Quaterly Results -
Feb 26, 1998 Accounts & Dividend -
Dec 12, 1997 Interim Dividend. -
Aug 21, 1997 Half Yearly Results -
Feb 21, 1997 Accounts & Dividend. -
Ex-Date Bonus Ratio Record Date
Sep 11, 2018 1:1 2018-09-13
Bigul
28 Jun 2024

GLAXOSMITHKLINE PHARMACEUTICALS LTD. - 500660 - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report

 Outcome of AGM
Bigul
28 Jun 2024

GLAXOSMITHKLINE PHARMACEUTICALS LTD. - 500660 - Shareholder Meeting / Postal Ballot-Outcome of AGM

 Outcome of AGM
Bigul
27 Jun 2024

GLAXOSMITHKLINE PHARMACEUTICALS LTD. - 500660 - Closure of Trading Window

 Trading window closure
Bigul
27 Jun 2024

GLAXOSMITHKLINE PHARMACEUTICALS LTD. - 500660 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

 Advance intimation under Regulation 39
Bigul
25 Jun 2024

New product launches may continue to fuel GSK Pharma's robust growth

 GSK Pharma's recent good showing is on expectations that launches in the specialty segment, increasing investments in promotions and branding
Bigul
25 Jun 2024

GLAXOSMITHKLINE PHARMACEUTICALS LTD. - 500660 - Disclosure Under Regulations 30

 Disclosure under Regulations 30
24 Jun 2024

GSK Pharma - Business In Recovery Model: Motilal Oswal

 Valuation adequately factors in the earnings upside
Bigul
24 Jun 2024

GLAXOSMITHKLINE PHARMACEUTICALS LTD. - 500660 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

 Advance intimation under Regulation 39
Bigul
20 Jun 2024

GLAXOSMITHKLINE PHARMACEUTICALS LTD. - 500660 - Disclosure Under Clause 30

 Disclosure under clause 30
Bigul
19 Jun 2024

GLAXOSMITHKLINE PHARMACEUTICALS LTD. - 500660 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

 Advance intimation under Regulation 39
See all News

FAQs

The latest market price of GlaxoSmithKline Pharmaceuticals Ltd. on NSE was Rs. 2603.70 as of today.

The opening share price of GlaxoSmithKline Pharmaceuticals Ltd. was Rs. 2620.10 as of today.

The 52-week high share price of GlaxoSmithKline Pharmaceuticals Ltd. was Rs. 2760.00.

The 52 week low share price of GlaxoSmithKline Pharmaceuticals Ltd. was Rs. 1377.20.

GlaxoSmithKline Pharmaceuticals Ltd. has a market cap of Rs. 44108.20 crore as of today. Please refer to the Fundamentals section for further details.

The PE ratio of GlaxoSmithKline Pharmaceuticals Ltd. is -22.00. Please refer to the Fundamentals section for further details.

The operating revenue for GlaxoSmithKline Pharmaceuticals Ltd. in the last FY was Rs.  3453.71 crore. Please refer to the Financials section for further details.

The Net Profit for GlaxoSmithKline Pharmaceuticals Ltd. in the last FY was Rs. 589.96 crore. Please refer to the Financials section for further details.

Please refer to Stock Ants, Bigul’s Community Access platform that aggregates tips and research from experts and provides real-time tracking to help investors validate, discover new investment ideas, and make informed decisions. Click here to learn more.

Please refer to Stock Ants, Bigul’s Community Access platform that aggregates tips and research from experts and provides real-time tracking to help investors validate, discover new investment ideas, and make informed decisions. Click here to learn more.

The latest dividend declared by GlaxoSmithKline Pharmaceuticals Ltd. was on 2024-05-31 for Rs. 32 per share. According to today’s share price, the dividend yield of GlaxoSmithKline Pharmaceuticals Ltd. stands at 1.20. Please refer to the Corporate Actions section for further details.

The latest bonus issue declared by GlaxoSmithKline Pharmaceuticals Ltd. was as of 2018-09-11. The bonus ratio declared in this issue was 1:1. Please refer to the Corporate Actions section for further details.

Please find Corporate actions section for more details.

Please refer to Bigul Traders Corner, One Stop destination for different algo and non-algo trading strategies and tools meant for investors, traders, and strategists. Our qualified experts with rich experience in broking, financial analysis, and software development designed it in-house. Click here to learn more.

Please refer to JARVIS, which is Bigul’s AI Portfolio Manager Tool that uses artificial intelligence algorithms to make investment decisions in a portfolio. Click here to learn more.

Please refer to the News section for the latest news about GlaxoSmithKline Pharmaceuticals Ltd..

Close

Let's Open Free Demat Account